The Melody A3 is an example of a hearing aid that does everything right, and at a price that is affordable to even those on a limited budget. The devices, approved by the FDA and made in the United States, have been creating quite the stir among health communities.

The introduction of the Melody A3 brought rave reviews for a simple reason: it featured a dual microphone in the ear piece that allows for stereo-like sound. Much like a surround sound system is in a different class than the mono sound from an old television, these hearing aids provide a completely different experience. Previous models such as the Melody A1 and A2 do not have this upgrade.

All hearing aids today have a noise filtering function to allow users to focus on important sound, and not the filler noise in the background. To put it into perspective, it’s like trying to listen to someone in a crowded room- you might catch yourself saying “What?” multiple times simply because of the background noise. The Melody A3 works to eliminate needless noise.

OTE hearing aid design was something the Melody designers targeted for its ease in maintaining, cleaning, and use. The Melody A3 is an over the ear design that is made of extremely light materials. Even if other OTE models have a reputation for being uncomfortable, the Melody A3 contours to the outer ear to the point where the wearer doesn’t even realize they have anything on! Of course, it also blends well so others don’t notice either.

The need for a hearing aid depends from one person to the next. While one person may only have a moderate hearing loss, others might have extreme or minimal hearing loss to worry about. The Melody A3 can cater to all levels of hearing loss, as it is stated to facilitate hearing aid for those with up to 110 dB in hearing loss. It’s certainly a very robust model, but sometimes even more extreme hearing loss can be apparent, and you may have to look at other opportunities.

Pricing on hearing aids will vary. The Melody A3 is one of the high-end products, so it can reach as high as $875 at the time of publishing. Lower end models from the Melody line of hearing aids are much less expensive, so if your budget isn’t at this level, they are a good “go to” for you. Retailers should be more than happy to handle questions and give out advice on the situation.

Final Thoughts

Over time, the Melody A3 has gained a lot of popularity among websites and retailers. The Melody A3 is a fine product that has held its name high with quality manufacturing. The manufacturer is constantly researching and developing new models for future expansions on the A3.

Learn more on digital hearing aids and hearing aids.

Part of the problem in finding drugs which may be effective for dementia is that our ideas about what constitutes dementia have been undergoing radical change in recent years. It had been traditional to distinguish between Alzheimer’s dementia, or senile dementia of the Alzheimer’s type (SDAT) and multi-infarct dementia (MID), which is theoretically caused by small strokes which insidiously pick off brain tissue to the point where an individual’s cognitive function is compromised.

It was originally thought that MID accounted for 60%+ of the dementias. Accordingly, early attempts to treat the dementias concentrated on the multi-infarct dementias. The initial hypothesis was that these multiple small strokes were being caused by a process of hardening of the arteries, sometimes called arteriosclerosis and sometimes atherosclerosis (although these terms refer to two quite different disorders) which impaired blood supply to the brain. The logical treatment, therefore, for this condition was to attempt to dilate blood vessels. This led to the use of a wide number of vasodilating drugs such as hydralazine.

It is quite rare now for such drugs to be used for this purpose. Arguably, if anything, such treatment may have made the condition somewhat worse in that a potential effect of vasodilators is the reduction of blood pressure and reducing blood pressure would mean that the brain would be less perfused with blood, as one of the functions of blood pressure in the first instance is to provide the propulsive force to send blood up against the force of gravity to perfuse the brain.

Stage 2

More recent attempts to treat the dementias have proceeded on the basis that Alzheimer’s dementia is the commonest form of dementia. For many years, the term Alzheimer’s dementia was reserved for dementias that came on before the age of 65 (for this reason it was also called persenile dementia), which were not obviously caused by strokes. It was conceded that there was another dementia that was like Alzheimer’s dementia, which appeared to come on after the age of 65 but this was thought to be less common. Distinctions on the basis of age have now collapsed and both dementias of the Alzheimer type are now called senile dementia of the Alzheimer type. The amalgamation of these two groups led to an awareness that Alzheimer’s-type dementia is the commonest form. The primary therapeutic focus in the field, therefore, has been on an attempt to reverse the deficits which are supposed to be present in SDAT.

In particular, it has been held that in Alzheimer’s, there is a dysfunction of cholinergic pathways in the brain, for which there are both historical and clinical reason. Historically, when early work in psychopharmacology began, there were only four known neurotransmitters – noradrenaline, 5-HT, dopamine and acetylcholine (ACh). Noradrenaline quickly became the neurotransmitter involved in depression and mood disorders. Dopamine was known to be involved in Parkinson’s disease, and, when it became clear that neuroleptics acted on it, schizophrenia, after which the psychoses in general came to be seen as disorders of dopamine neurotransmission. For the most part, 5-HT was associated with either depression or anxiety. This left ACh without a function. It seemed convenient to parcel it out to the dementias.

There was, in addition, some clinical evidence in favour of an association between the cholinergic system and dementia. Part of the reason for this claim can be seen in a number of the chapters of this blog, in which drugs with anticholinergic effects have been noted as potentially causing amnesia or confusion (see The Management of Side Effects & Side Effects of Antidepressants articles).

Stage 3

In the last 5 years, a number of other dementias have been described. A distinction has been drawn between cortical and subcortical dementias. The cortex of the brain is the area responsible for higher cognitive functions, such as speaking, reading, planning and executing actions, etc In the cortical dementias, memory is usually the function most noticeably affected but those who are affected also have problems with planning even simple functions such as dressing and they typically cannot read, draw or execute any complex tasks. Alzheimer’s and MID are cortical dementias. There are also subcortical parts to the brain which are common to humans and other mammals. They involve a number of what are termed midbrain and brainstem structures.

Read more at dementia managing